David F Heigener

David F Heigener

UNVERIFIED PROFILE

Are you David F Heigener?   Register this Author

Register author
David F Heigener

David F Heigener

Publications by authors named "David F Heigener"

Are you David F Heigener?   Register this Author

26Publications

566Reads

28Profile Views

Redefining Treatment Paradigms in First-line Advanced Non-Small-Cell Lung Cancer.

Clin Cancer Res 2019 Aug 25;25(16):4881-4887. Epub 2019 Mar 25.

Airway Research Center North in the German Center for Lung Research (DZL), Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1894DOI Listing
August 2019

Crizotinib.

Recent Results Cancer Res 2018;211:57-65

Department of Thoracic Oncology, LungenClinic Grosshansdorf, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-91442-8_4DOI Listing
November 2018

Impact of PD-L1 Expression in EGFR-Positive NSCLC? The Answer Remains the Same….

J Thorac Oncol 2018 08 2;13(8):1060-1061. Epub 2018 Jul 2.

Thoracic Oncology, LungenClinic Großhansdorf, Großhansdorf, Germany; Airway Research Center North, German Center for Lung Research (DZL), Großhansdorf, Germany; University of Lübeck, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2018.06.001DOI Listing
August 2018

Advanced non-small cell lung cancer: the role of PD-L1 inhibitors.

J Thorac Dis 2018 May;10(Suppl 13):S1468-S1473

Lungenclinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/jtd.2018.01.112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994502PMC
May 2018

Lung cancer in 2017: Giant steps and stumbling blocks.

Nat Rev Clin Oncol 2018 02 21;15(2):71-72. Epub 2017 Nov 21.

Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Centre North (ARCN), German Center for Lung Research (DZL), Woehrendamm 80, Grosshansdorf, Schleswig-Holstein 22927, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2017.178DOI Listing
February 2018

Efficacy and Safety of Nintedanib Plus Docetaxel in Patients with Advanced Lung Adenocarcinoma: Complementary and Exploratory Analyses of the Phase III LUME-Lung 1 Study.

Target Oncol 2017 08;12(4):475-485

Department of Thoracic Oncology, LungenClinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), 22927, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11523-017-0517-2DOI Listing
August 2017

Second-Line Treatment Selection in Patients With Non-Small-Cell Lung Cancer of Adenocarcinoma Histology: Findings From a European Survey of Treating Physicians.

Clin Lung Cancer 2017 03 26;18(2):e89-e97. Epub 2016 Oct 26.

Thoracic Oncology, Lungen Clinic Grosshansdorf, Member of the German Center for Lung Research, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2016.10.004DOI Listing
March 2017

PD-1 Axis Inhibition in EGFR Positives: A Blunt Sword?

J Thorac Oncol 2017 02;12(2):171-172

Department of Thoracic Oncology, Lung Clinic Grosshansdorf, Grosshansdorf, Germany. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.12.013DOI Listing
February 2017

Targeting of MEK in lung cancer therapeutics.

Lancet Respir Med 2015 Apr 20;3(4):319-27. Epub 2015 Mar 20.

Department of Thoracic Oncology, LungenClinic Grosshansdorf; member of the Airway research center north (ARCN) as part of the German Centre for Lung Research (DZL), Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(15)00026-0DOI Listing
April 2015

[Non-small cell lung cancer: news from immunotherapy].

Dtsch Med Wochenschr 2015 Mar 3;140(5):329-33. Epub 2015 Mar 3.

Abteilung für Thorakale Onkologie, LungenClinic Grosshansdorf, Grosshansdorf, Deutschland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-0041-100763DOI Listing
March 2015

Crizotinib.

Recent Results Cancer Res 2014 ;201:197-205

Department of Thoracic Oncology, LungenClinic Grosshansdorf, Grosshansdorf, Germany,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/978-3-642-54490-3_11
Publisher Site
http://dx.doi.org/10.1007/978-3-642-54490-3_11DOI Listing
September 2014

Management of non-small-cell lung cancer: recent developments.

Lancet 2013 Aug;382(9893):709-19

LungenClinic Grosshansdorf, Airway Research Center North, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(13)61502-0DOI Listing
August 2013

Second-line erlotinib in patients with advanced non-small-cell lung cancer: subgroup analyses from the TRUST study.

Lung Cancer 2011 Nov 24;74(2):274-9. Epub 2011 Mar 24.

Hospital Grosshansdorf, Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.02.017DOI Listing
November 2011

Non-small cell lung cancer in never-smokers: a new disease entity?

Authors:
David F Heigener

Onkologie 2011 18;34(4):202-7. Epub 2011 Mar 18.

Department of Thoracic Oncology, Krankenhaus Grosshansdorf, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000326839DOI Listing
September 2011

Costs of bevacizumab and pemetrexed for advanced non-squamous NSCLC in Italy and Germany.

Lung Cancer 2010 Aug;69 Suppl 1:S18-23

Thoraxklinik Heidelberg GmbH, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0169-5002(10)70134-3DOI Listing
August 2010

[Non-small cell lung cancer - diagnostics and stage-adapted therapy].

Med Klin (Munich) 2007 Dec;102(12):981-8; quiz 989-90

Onkologischer Schwerpunkt, Krankenhaus Grosshansdorf.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00063-007-1122-4DOI Listing
December 2007